Akero Therapeutics shares plunge on liver disease treatment’s mixed results
October 10, 2023 at 08:10 AM EDT
Company's lead product candidate shows some benefit for patients with cirrhosis due to fatty liver disease
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
